The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma.
a Department of Haematology , St Vincent's Hospital , Melbourne , Australia.
Louise
L
Kostos
a Department of Haematology , St Vincent's Hospital , Melbourne , Australia.
Khai Li
KL
Chai
a Department of Haematology , St Vincent's Hospital , Melbourne , Australia.|b Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Australia.|c University of Melbourne , Parkville , Victoria , Australia.
Constantine S
CS
Tam
a Department of Haematology , St Vincent's Hospital , Melbourne , Australia.
Ali
A
Bazargan
D000368:Aged; D001565:Benzoates / Q000494:pharmacology*; D001853:Bone Marrow / Q000473:pathology*; D000077588:Deferasirox; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D006801:Humans; D061705:Image-Guided Biopsy; D007150:Immunohistochemistry; D007502:Iron Chelating Agents / Q000494:pharmacology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000628:therapy; D008279:Magnetic Resonance Imaging; D049268:Positron-Emission Tomography; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000628:therapy; D014230:Triazoles / Q000494:pharmacology*
D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox